Scientific opinion on toxicity of pyrethroid common metabolites

Archive ouverte

Hernandez-Jerez, Antonio F. | Adriaanse, Paulien | Aldrich, Annette | Berny, Philippe | Duquesne, Sabine | Focks, Andreas | Marinovich, Marina | Millet, Maurice | Pelkonen, Olavi | Pieper, Silvia | Tiktak, Aaldrik | Topping, Christopher J | Widenfalk, Anneli | Wilks, Martin | Wolterink, Gerrit | Binaglia, Marco | Chiusolo, Arianna | Serafimova, Rositsa | Terron, Andrea | Coja, Tamara

Edité par CCSD ; European Food Safety Authority -

3/2. International audience. The EFSA Panel on Plant Protection Products and their Residues was requested by the European Commission, to conclude based upon available evidence if metabolites 3-phenoxybenzoic acid (PBA) and 3-(40-hydroxyphenoxy)benzoic acid (PBA(OH)), common to several pyrethroid compounds, have genotoxic properties, if they share the (neuro)toxicity profile of their parent compounds, and if evidence allows to conclude on their health-based guidance values. Available body of evidence consisted of studies from regulatory dossiers submissions, as well as from public literature. In addition, the data gap for short-term toxicity profile of PBA was addressed by read-across. Assessment revealed that PBA and PBA(OH) do not raise a concern with respect to genotoxicity. As regards general toxicity, PBA and PBA(OH) have different qualitative (no neurotoxic mechanism) and quantitative (higher NOAELs) toxicity compared to the parent pyrethroid compounds. For both metabolites, acceptable daily intake (ADI) and acute reference dose (ARfD) values were derived at 0.1 mg/kg body weight (bw) per day and 1 mg/kg bw, respectively.

Consulter en ligne

Suggestions

Du même auteur

Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative in vitro metabolism studies

Archive ouverte | Hernandez‐jerez, Antonio, F | CCSD

International audience. EFSA asked the Panel on Plant Protection Products and their residues to deliver a Scientific Opinion on testing and interpretation of comparative in vitro metabolism studies for both new acti...

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome

Archive ouverte | Hernandez-Jerez, Antonio | CCSD

International audience. Development of adverse outcome pathways (AOPs) for uterine adenocarcinoma can provide a practical tool to implement the EFSA-ECHA Guidance (2018) for the identification of endocrine disruptor...

Statement on the active substance flupyradifurone

Archive ouverte | Hernandez Jerez, Antonio | CCSD

3/2. International audience. Flupyradifurone is a novel butenolide insecticide, first approved as an active substance for use in plant protection products by Commission Implementing Regulation (EU) 2015/2084. Follow...

Chargement des enrichissements...